Envestnet Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $262M | Buy |
9,345,601
+697,500
| +8% | +$18.6M | 0.07% | 253 |
|
|
2025
Q4 | $215M | Sell |
8,648,101
-1,381,572
| -14% | -$34.8M | 0.06% | 282 |
|
|
2025
Q3 | $256M | Sell |
10,029,673
-1,165,407
| -10% | -$28.8M | 0.07% | 250 |
|
|
2025
Q2 | $271M | Buy |
11,195,080
+792,967
| +8% | +$18.5M | 0.08% | 232 |
|
|
2025
Q1 | $264M | Buy |
10,402,113
+1,231,296
| +13% | +$32.2M | 0.09% | 222 |
|
|
2024
Q4 | $243M | Sell |
9,170,817
-754,199
| -8% | -$20.5M | 0.08% | 230 |
|
|
2024
Q3 | $287M | Sell |
9,925,016
-335,051
| -3% | -$9.77M | 0.09% | 199 |
|
|
2024
Q2 | $287M | Buy |
10,260,067
+238,850
| +2% | +$6.58M | 0.1% | 188 |
|
|
2024
Q1 | $278M | Buy |
10,021,217
+1,991,537
| +25% | +$55.3M | 0.1% | 190 |
|
|
2023
Q4 | $231M | Sell |
8,029,680
-247,627
| -3% | -$7.49M | 0.1% | 196 |
|
|
2023
Q3 | $275M | Buy |
8,277,307
+1,437,300
| +21% | +$50.8M | 0.13% | 150 |
|
|
2023
Q2 | $251M | Sell |
6,840,007
-1,174,642
| -15% | -$45.7M | 0.11% | 155 |
|
|
2023
Q1 | $258M | Buy |
8,014,649
+2,140,952
| +36% | +$92.5M | 0.12% | 140 |
|
|
2022
Q4 | $301M | Sell |
5,873,697
-381,842
| -6% | -$18.3M | 0.16% | 112 |
|
|
2022
Q3 | $274M | Buy |
6,255,539
+403,638
| +7% | +$19.6M | 0.16% | 113 |
|
|
2022
Q2 | $307M | Buy |
5,851,901
+1,206,759
| +26% | +$61.5M | 0.17% | 105 |
|
|
2022
Q1 | $240M | Buy |
4,645,142
+210,582
| +5% | +$10.9M | 0.12% | 149 |
|
|
2021
Q4 | $262M | Sell |
4,434,560
-523,015
| -11% | -$25.9M | 0.13% | 143 |
|
|
2021
Q3 | $213M | Sell |
4,957,575
-356,096
| -7% | -$15.8M | 0.12% | 152 |
|
|
2021
Q2 | $208M | Buy |
5,313,671
+421,711
| +9% | +$16.4M | 0.12% | 147 |
|
|
2021
Q1 | $177M | Buy |
4,891,960
+448,943
| +10% | +$15.9M | 0.12% | 150 |
|
|
2020
Q4 | $164M | Sell |
4,443,017
-306,070
| -6% | -$11.2M | 0.12% | 132 |
|
|
2020
Q3 | $165M | Buy |
4,749,087
+25,091
| +0.5% | +$880K | 0.15% | 116 |
|
|
2020
Q2 | $147M | Sell |
4,723,996
-201,898
| -4% | -$6.86M | 0.14% | 117 |
|
|
2020
Q1 | $153M | Buy |
4,925,894
+794,979
| +19% | +$27.1M | 0.18% | 95 |
|
|
2019
Q4 | $154M | Buy |
4,130,915
+748,445
| +22% | +$26.7M | 0.16% | 107 |
|
|
2019
Q3 | $115M | Buy |
3,382,470
+178,080
| +6% | +$6.48M | 0.13% | 131 |
|
|
2019
Q2 | $132M | Buy |
3,204,390
+207,946
| +7% | +$8.26M | 0.17% | 100 |
|
|
2019
Q1 | $121M | Buy |
2,996,444
+104,346
| +4% | +$4.18M | 0.17% | 98 |
|
|
2018
Q4 | $120M | Buy |
2,892,098
+2,813,550
| +3,582% | +$117M | 0.19% | 91 |
|
|
2018
Q3 | $3.28M | Sell |
78,548
-434,586
| -85% | -$16.7M | 0.01% | 505 |
|
|
2018
Q2 | $17.7M | Buy |
513,134
+20,546
| +4% | +$702K | 0.04% | 206 |
|
|
2018
Q1 | $16.5M | Sell |
492,588
-652,990
| -57% | -$22.4M | 0.05% | 148 |
|
|
2017
Q4 | $39.4M | Buy |
1,145,578
+108,057
| +10% | +$3.68M | 0.09% | 118 |
|
|
2017
Q3 | $35.1M | Sell |
1,037,521
-85,405
| -8% | -$2.74M | 0.08% | 123 |
|
|
2017
Q2 | $35.8M | Sell |
1,122,926
-13,989
| -1% | -$441K | 0.1% | 126 |
|
|
2017
Q1 | $36.9M | Buy |
1,136,915
+49,716
| +5% | +$1.57M | 0.12% | 115 |
|
|
2016
Q4 | $33.5M | Buy |
1,087,199
+118,538
| +12% | +$3.62M | 0.12% | 116 |
|
|
2016
Q3 | $31.1M | Sell |
968,661
-338,587
| -26% | -$11.3M | 0.12% | 135 |
|
|
2016
Q2 | $43.7M | Sell |
1,307,248
-11,462
| -0.9% | -$366K | 0.17% | 94 |
|
|
2016
Q1 | $37.1M | Sell |
1,318,710
-208,029
| -14% | -$5.94M | 0.16% | 107 |
|
|
2015
Q4 | $46.8M | Sell |
1,526,739
-87,815
| -5% | -$2.76M | 0.21% | 84 |
|
|
2015
Q3 | $48.1M | Sell |
1,614,554
-111,422
| -6% | -$3.57M | 0.24% | 70 |
|
|
2015
Q2 | $54.9M | Buy |
1,725,976
+104,651
| +6% | +$3.41M | 0.26% | 71 |
|
|
2015
Q1 | $53.5M | Buy |
1,621,325
+1,402,743
| +642% | +$44.6M | 0.28% | 76 |
|
|
2014
Q4 | $6.46M | Sell |
218,582
-53,773
| -20% | -$1.54M | 0.07% | 185 |
|
|
2014
Q3 | $7.64M | Buy |
272,355
+6,728
| +3% | +$189K | 0.08% | 178 |
|
|
2014
Q2 | $7.48M | Buy |
265,627
+30,953
| +13% | +$882K | 0.08% | 198 |
|
|
2014
Q1 | $7.15M | Buy |
234,674
+942
| +0.4% | +$28.1K | 0.08% | 173 |
|
|
2013
Q4 | $6.79M | Buy |
233,732
+28,809
| +14% | +$838K | 0.08% | 167 |
|
|
2013
Q3 | $5.58M | Buy |
204,923
+115,407
| +129% | +$3.14M | 0.07% | 178 |
|
|
2013
Q2 | $2.38M | Buy |
+89,516
| New | +$2.47M | 0.03% | 254 |
|
Other funds holding PFE
VCM
VPM
Envestnet Asset Management's PFE Position: Q1 2026 in Review
Envestnet Asset Management increased its Pfizer (PFE) stake by 8.1% in Q1 2026, buying an estimated $18.6M and bringing the position to 9,345,601 shares worth $262M. The position accounts for 0.07% of the portfolio, ranked #253.
Envestnet Asset Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $307M in Q2 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Envestnet Asset Management held 9,345,601 shares of Pfizer worth $262M as of Q1 2026.
- Envestnet Asset Management bought 697,500 Pfizer shares in Q1 2026, an estimated $18.6M.
- Pfizer made up 0.07% of Envestnet Asset Management's portfolio in Q1 2026, its #253 holding.
- Envestnet Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Envestnet Asset Management's Pfizer position peaked at $307M in Q2 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.